RayzeBio, Inc.

CIK 1825367 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for RayzeBio, Inc..

Recent SEC filings

FiledFormAccession number
Mar 7, 202415-12G0001140361-24-011946
Feb 28, 202440000905148-24-000813
Feb 28, 202440000905148-24-000814
Feb 28, 2024SC 13G/A0000905148-24-000812
Feb 27, 202440001415889-24-005511
Feb 27, 202440001415889-24-005516
Feb 27, 202440001415889-24-005525
Feb 27, 202440001415889-24-005507
Feb 27, 202440001415889-24-005500
Feb 27, 202440001415889-24-005541
Feb 27, 202440001415889-24-005502
Feb 27, 202440001415889-24-005545
Feb 27, 202440001415889-24-005538
Feb 27, 202440001415889-24-005551
Feb 26, 202425-NSE0001354457-24-000109
Feb 26, 20248-K0001140361-24-009377
Feb 26, 2024S-8 POS0001140361-24-009378
Feb 23, 2024SC 14D9/A0001140361-24-009148
Feb 23, 2024SC TO-T/A0001140361-24-009146
Feb 16, 2024SC TO-T/A0001140361-24-008300
Feb 14, 2024SC 13G/A0001104659-24-024221
Feb 14, 2024SC 14D9/A0001140361-24-007741
Feb 12, 2024SC 14D9/A0001140361-24-006886
Feb 12, 2024SC TO-T/A0001140361-24-006876
Feb 9, 2024SC 13G0000905148-24-000534